Coya Therapeutics, Inc. (COYA)

NASDAQ: COYA · Real-Time Price · USD

4.900

+0.220 (4.70%)

Feb 24, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biotechnology	3.55M	6.00M
Biotechnology Growth	-40.79%	-
Total	3.55M	6.00M
Total Growth	-40.79%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	3.55M	6.00M
United States Growth	-40.79%	-
Total	3.55M	6.00M
Total Growth	-40.79%	-

Source: S&P Global Market Intelligence.